(A) Schema depicting the Lucky Luke bicistronic construct and HL-1 cells transduced by a lentivector carrying the transgene. The LucF/LucR ratio indicates the IRES activity. (B) Activity of the …
Renilla (A) and firefly (B) luciferase activities were measured in HL-1 cardiomyocytes transduced by the bicistronic vector with the FGF1 IRES, after 4 hr, 8 hr, or 24 hr of hypoxia or normoxia. The …
FISH experiment with representative images of Neat1 (both isoforms)(left panels) or Neat1_2 isoform (right panels) in normoxia and hypoxia at 4 hr, 8 hr, 24 hr in HL-1 cardiomyocytes. DAPI, Neat1 …
(A–B) 67NR cells (mouse breast cancer) were subjected to normoxia (0 hr) or to hypoxia (1% 02) during 4 hr, 8 hr and 24 hr. Neat1 (A) or Neat1_2 (B) expression was analyzed by RT qPCR (Primer …
(A) SmiFISH imaging of Neat1 knock-down by a pool of LNA gapmers targeting both isoforms (Sequences in Supplementary file 2C). Cells were treated during 48 hr with the gapmers. Scale bar = 10 µm. (B)…
Neat1 knock-down was performed in HL-1 cells using pooled LNA gapmers against Neat1 (48 hr)(A) or Neat1_2 (72 hr)(B). Neat1 and Neat1_2 RNA expression was measured by droplet digital PCR and …
Endogenous mouse FGF1 was detected using anti-FGF1 antibody in hypoxic HL-1 cells treated either by control gapmer (ctrl) or Neat1_2 gapmer by capillary Simple Western. The source data of the …
Neat1-2 knock-down was performed in HL-1 cells transduced by the bicistronic lentivector with the FGF1 IRES during normoxia or hypoxia (1% O2). Luciferase activities as well as the LucF/LucR ratios …
Expression and phosphorylation of eIF2α in HL-1 cells either untreated (NT) or treated by control gapmer (ctrl) or Neat1_2 gapmer were measured using anti-eIF2α (A) and anti-phospho-eIF2α antibodies …
(A–E) FGF1 half-life was determined in HL-1 cells treated with control gapmer, Neat1_2 gapmer or untreated. The half-life determination was performed by blocking protein synthesis with cycloheximide …
(A–E) p21 half-life half-life was determined as a control in HL-1 cells treated with control gapmer, Neat1_2 gapmer or untreated, in the experiment shown in Figure 2—figure supplement 5. p21 protein …
Cells were transduced with lentivectors carrying bicistronic Lucky Luke constructs with the FGF1 IRES or a hairpin (control), subjected or not to 4 hr hypoxia. SmiFISH experiments were performed. (A)…
(A) Schema of paraspeckle and DBHS proteins. (B–D) FGF1 IRES activity upon knock-down of SFPQ (B), P54nrb (C) or PSPC1 (D) in HL-1 cell (Figure 4—figure supplement 1—source data 1) transduced with …
(A–B) Capillary Simple Western detection (as described in Figure 2) of p54nrb (A) and PSPC1 (B) proteins using anti-p54nrb and anti-PSPC1 antibodies, respectively, following p54nrb and PSPC1 …
Endogenous FGF1 protein was detected by Capillary Simple Western in conditions of P54nrb or PSPC1 knock-down mentioned in Figure 4—figure supplement 1. The raw data presented correspond to the …
FGF1 half-life was determined on HL-1 cells treated with p54nrb siRNA, PSPC1 siRNA or control siRNA, by blocking protein synthesis with cycloheximide at 10 μg/mL, with time-course points at 0 hr, 30 …
p21 half-life was determined on HL-1 cells treated with p54nrb siRNA, PSPC1 siRNA or control siRNA in the same experiment as in that presented in Figure 4—figure supplement 3. p21 protein stability …
(A) Experimental workflow: p54nrb-HA transduced HL-1 cells were subjected to normoxia or hypoxia, then nucleus and cytoplasm fractionation was performed and extracts were immunoprecipitated using …
(A-B) Raw data of the Western blots using nuclear or cytoplasmic extracts of HL-1 cells in normoxia and hypoxia, presented in Figure 5B. (A) Western blot successively blotted with anti-GAPDH, …
Immunoprecipitation was performed from HL-1 cell nuclear extracts, using either IgG (negative control), or antibody against p54nrb, or antibody against nucleolin. Capillary Simple Western (Jess) was …
(A–C) Quantification of RPS2 (A), hnRNPM (B) and nucleolin (C) RNA expression in HL-1 cells transfected with siRNAs against Rps2, hnRNPM or nucleolin mRNA, respectively. RNA expression was measured …
Knock-down of nucleolin was achieved in HL-1 cells using siRNA against nucleolin mRNA. Capillary Simple Western were performed using anti-nucleolin (A) of anti-FGF1 antibody (B). The source data of …
(A–C) HL-1 subjected to normoxia or 1% O2 hypoxia were transduced by Lucky Luke bicistronic lentivectors with FGF1, FGF2, VEGFAa, VEGFAb, VEGFC, VEGFD, IGF1R, MYC, or EMCV IRES, then the knock-down …
HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1_2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. The polysome profile is presented in Figure …
In order to isolate translated mRNAs, polysomes from transfected HL-1 cardiomyocytes were purified on a sucrose gradient, as described in Star Methods. Polysomal profiles of HL-1 cardiomyocytes …
HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1-2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. Polysome profile is presented in Figure …
According to the present data, we propose that the paraspeckle may be a recruitment platform for IRES-containing mRNAs in hypoxic cardiomyocytes. Neat1 and proteins present in the paraspeckle (among …
Mouse atrial HL-1 cardiomyocytes exhibit a beating phenotype when cultured in Claycomb medium at high density (Claycomb et al., 1998). This phenotype was required to obtain all the data described in …
The paraspeckle components listed in the reports by Naganuma et al., 2012 and by Yamamoto et al., 2021 is presented here with their ITAF function and their presence in the p54nrb interactome. Their …
Name | Alternative name | Class | ITAF | Presence in p54nrb MS-IP |
---|---|---|---|---|
ASXL1 | MDS/BOPS | I | No | No |
CELF6 | n/d | No | No | |
CIRBP | IIIB | No | Yes | |
CPSF6 | IIIA | No | Yes | |
CPSF7 | II | No | Yes | |
DAZAP1 | IB | No | Yes | |
DLX3 | n/d | No | No | |
EWSR1 | No | Yes | ||
FAM113A | II | No | No | |
FAM98A | II | No | Yes | |
FIGN | II | No | No | |
FUS | IB | Yes | Yes | |
FUSPI1 | SRSF10 | II | No | Yes |
hnRNPA1 | II | Yes | Yes | |
hnRNPA1L2 | n/d | No | No | |
hnRNPF | n/d | No | Yes | |
hnRNPH1 | n/d | No | Yes | |
hnRNPH3 | IB | No | No | |
hnRNPK | IA | Yes | Yes | |
hnRNPM | n/d | Yes | Yes | |
hnRNPR | II | Yes | No | |
hnRNPUL1 | II | No | Yes | |
MEX3C | n/d | No | No | |
NUDT21 | IIIA | No | Yes | |
p54nrb | NONO | IA | Yes | Yes |
PSPC1 | IIIB | No | Yes | |
RBM12 | II | No | No | |
RBM14 | IA | No | No | |
RBM3 | IIIB | No | Yes | |
RBM4B | IIIB | No | No | |
RBM7 | IIIB | No | No | |
RBMX | IIIB | No | Yes | |
RUNX3 | IIIB | No | No | |
SFPQ | PSF | IA | Yes | Yes |
SS18L1 | n/d | No | No | |
SWI/SNF | IB | No | No | |
TAF15 | No | No | ||
TDP-43 | II | No | No | |
UBAP2L | IIIA | No | Yes | |
ZNF335 | TARDBP | IIIB | No | Yes |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Anti-P54nrb (rabbit polyclonal) | Santacruz | Sc-67016 | Dilution 1:200 (capillary Western) Dilution 1:400 (classical Western) |
Antibody | Anti-PSPC1 (rabbit polyclonal) | bethyl laboratory | A303-205A | Dilution 1:100 (capillary Western) Dilution 1:1000 (classical Western) |
Antibody | Anti-SFPQ (mouse monoclonal) | Abcam | Ab11825 | Dilution 1:100 |
Antibody | Anti-FGF1 (rabbit polyclonal) | Abcam | Ab207321 | Dilution 1:25 |
Antibody | Anti-nucleolin (rabbit polyclonal) | Novus biological | NB600-241 | Dilution 1:50 |
Antibody | Anti-Histone H3 (rabbit polyclonal) | Cell Signaling | 4499 | Dilution 1 : 10000 |
Antibody | Anti-GAPDH (mouse monoclonal) | SantaCruz | Sc-32233 | Dilution 1:1000 |
Antibody | Mouse total IgG (mouse polyclonal) | Sigma | I5381 | 2 mg/mL |
Antibody | Anti-eIF2α (rabbit polyclonal) | Cell Signaling Technology | 9721 | Dilution 1:50 |
Antibody | Anti-phospho-eIF2α (mouse monoclonal) | Cell Signaling Technology | 2103 | Dilution 1:50 |
Antibody | Anti-p21 (mouse monoclonal) | Santacruz | Sc-6246 | Dilution 1:50 |
Antibody | Anti-HA (mouse monoclonal) | Sigma | H9558/H3663 | 2.4 mg/mL (72 μg) |
Antibody | Anti-rabbit-peroxidase conjugate (donkey polyclonal) | Jackson ImmunoResearch | 711-035-152 | Dilution 1:10000 |
Antibody | Anti-mouse-peroxidase conjugate (rabbit polyclonal) | Jackson ImmunoResearch | 715-035-150 | Dilution 1:10000 |
Antibody | Rabbit detection module | Protein Simple | DM-001 | 10 μl |
Antibody | Mouse detection module | Protein Simple | DM-002 | 10 μl |
Strain, strain background (Escherichia coli) | Top10 | InVitrogen | C404003 | |
Strain, strain background (Escherichia coli) | Strataclone | Agilent technologies | 200185 | |
Chemical compound, drug | TRI-Reagent | MRC Inc | TR118 | |
Chemical compound, drug | Isopropanol | Sigma-Aldrich | 33539 | |
Chemical compound, drug | Ethanol | Sigma-Aldrich | 32221 | |
Chemical compound, drug | Digitonin | Sigma-Aldrich | D141 | |
Chemical compound, drug | NP40 (IGEPAL 630) | Sigma-Aldrich | I8896 | |
Chemical compound, drug | EDTA | Euromedex | EU0084-A | |
Chemical compound, drug | Proteinase inhibitor cocktail | Sigma-Aldrich | P2714 | |
Chemical compound, drug | RNAse inhibitor | AppliedBiosystem | N8080119 | |
Chemical compound, drug | Formamide | Invitrogen | 15515026 | |
Chemical compound, drug | Paraformaldehyde 16% | Electron Microscopy Science | ||
Chemical compound, drug | SSC saline-sodium citrate buffer | Euromedex | EU0300-C | |
Chemical compound, drug | RIPA | BioBasic | RB4476 | |
Peptide, recombinant protein | HA peptides | Sigma-Aldrich | I2149 | |
Commercial assay or kit | Premix Ex Taq II | Takara | RR820B | |
Commercial assay or kit | EZ view red protein G beads | Sigma | E3403 | |
Commercial assay or kit | DG32 cartridge | Bio-Rad | #1864108 | |
Commercial assay or kit | QX200 ddPCR EvaGreen Supermix | Bio-Rad | 1864034 | |
Commercial assay or kit | High capacity cDNA Reverse transcription kit | Thermofisher | 4368814 | |
Commercial assay or kit | NucleoBond Xtra Maxi kits | Macherey-Nagel | 740414.10 | |
Commercial assay or kit | EZ-10 Spin Column Plasmid DNA Miniprep Kit | BioBasic | BS413 | |
Commercial assay or kit | StrataClone Blunt PCR Cloning Kit | Agilent | 240207 | |
Commercial assay or kit | Dual-Luciferase Reporter Assay system | Promega | E1980 | |
Commercial assay or kit | Jess or Wes Separation Module | ProteinSimple | SM-SW004 | |
Commercial assay or kit | Fluorescent 5 x Master Mix 1 | ProteinSimple | PS-FL01-8 | |
Cell line (Homo-sapiens) | 293 FT | Invitrogen | R700-07 | |
Cell line (Homo-sapiens) | HT1080 | ATCC | CCL-121 | |
Cell line (Mus musculus) | HL-1 | (Claycomb et al., 1998) / Sigma-Aldrich | SCC065 | Beating cardiomyocytes (Video 1) |
Sequence-based reagent | NEAT1 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | FGF1 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | NEAT1_2 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | HPRT | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | RPL11 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | 18 S | Hantelys et al., 2019 | PCR primers | Supplementary file 2 |
Sequence-based reagent | SFPQ | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | P54nrb | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | PSPC1 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | NUCLEOLIN | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | RPS2 | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | HNRNPM | Hantelys et al., 2019 | PCR primers | Supplementary file 2 |
Sequence-based reagent | Fluidigm deltagene probes | This paper | PCR primers | Supplementary file 2 |
Sequence-based reagent | Neat1 and Neat1_2 FISH probes | This paper | Hybridization probes | Supplementary file 2 |
Sequence-based reagent | SmiFISH secondary probes (FLAP X-Cy3 and FLAP-Y-Cy5) | This paper | Hybridization probes | Supplementary file 2 |
Sequence-based reagent | SmiFISH Neat1 primary probes | This paper | Hybridization probes | Supplementary file 2 |
Sequence-based reagent | SmiFISH bicistronic Lucky Luke mRNA primary probes | This paper | Hybridization probes | Supplementary file 2 |
Sequence-based reagent | HA-p54nrb | This paper | Cloning primers | Supplementary file 2 |
Sequence-based reagent | miR-Neat1-G2 | This paper | Cloning primers | Supplementary file 2 |
Sequence-based reagent | miR-Neat1_2-G6 | This paper | Cloning primers | Supplementary file 2 |
Sequence-based reagent | miR-Neat1_2-G7 | This paper | Cloning primers | Supplementary file 2 |
Sequence-based reagent | P54nrb mouse | Dharmacon E-048587-01-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | PSPC1 mouse | Dharmacon E-049216-00-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | SFPQ mouse | Dharmacon E-044760-00-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | Nucleolin mouse | Dharmacon E-059054-00-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | Rps2 mouse | Dharmacon E-049205-00-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | hnRNPM mouse | Dharmacon E-044465-00-0005 | siRNA smartpool | Supplementary file 2 |
Sequence-based reagent | siRNA non-targeting control | Dharmacon D-001910-10-20 | siRNA | Supplementary file 2 |
Sequence-based reagent | NEAT1 A | LG00218175 | LNA gapmer | Supplementary file 2 |
Sequence-based reagent | NEAT1 B | LG00218176 | LNA gapmer | Supplementary file 2 |
Sequence-based reagent | NEAT1 C | LG00218177 | LNA gapmer | Supplementary file 2 |
Sequence-based reagent | NEAT1 D | LG00218178 | LNA gapmer | Supplementary file 2 |
Sequence-based reagent | NEAT1_2 | LG00234548 | LNA gapmer | Supplementary file 2 |
Sequence-based reagent | NEGATIVE CONTROL | LG00000002 | LNA gapmer | Supplementary file 2 |
Recombinant DNA reagent | pTRIP-CRHL+ | Sequence available on Dryad, (2) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRF1AL+ | Sequence available on Dryad, (17; 26) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRFL+ | Sequence available on Dryad, (25) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRVAaL+ | Sequence available on Dryad, (16) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRVAbL+ | Sequence available on Dryad, (16) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRhVCL+ | Sequence available on Dryad, (2) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRhVDL+ | Sequence available on Dryad, (13) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRMP2L+ | Sequence available on Dryad, (42) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CREL+ | Sequence available on Dryad, (25) | SIN lentivector plasmid | doi:10.5061/dryad.nvx0k6dq7 |
Recombinant DNA reagent | pTRIP-CRIGL+ | This paper | SIN lentivector plasmid | doi:10.5061/dryad.m0cfxpp75 |
Recombinant DNA reagent | pCMV-dR8.91 | Addgene | Plasmid for lentivector production | |
Recombinant DNA reagent | pCMV-VSV-G | Addgene | Plasmid for lentivector production | |
Recombinant DNA reagent | pTRIP-Neat1-miR-G2 | This paper | SIN lentivector plasmid | doi:10.5061/dryad.m0cfxpp75 |
Recombinant DNA reagent | pTRIP-Neat1_2-miR-G6 | This paper | SIN lentivector plasmid | doi:10.5061/dryad.m0cfxpp75 |
Recombinant DNA reagent | pTRIP-Neat1_2-miR-G7 | This paper | SIN lentivector plasmid | doi:10.5061/dryad.m0cfxpp75 |
Recombinant DNA reagent | pTRIP-HA2-P54nrb | This paper | SIN lentivector plasmid | doi:10.5061/dryad.m0cfxpp75 |
Software, algorithm | Prism 6 | Graphpad | Software to perform statistics | https://www.graphpad.com/scientific-software/prism/ |
Software, algorithm | Excel 2007 | Microsoft office | Software to perfom graphs and tables | |
Software, algorithm | FIJI | FIJI | Software for image analysis | https://fiji.sc/ |
Software, algorithm | ImageJ | ImageJ/NIH | Software for image analysis | https://imagej.nih.gov/ij/download.html |
Software, algorithm | Zen black/Blue edition | Zeiss | Microscope software | https://www.zeiss.fr/microscopie/produits/microscope-software/zen-lite.html |
Software, algorithm | QuantStudio | AppliedBiosystems | Quantification software | https://www.thermofisher.com/fr/fr/home/global/forms/life-science/quantstudio-3-5-software.html |
Software, algorithm | QuantaSoft 1.7.4 | Bio-Rad | Western blot quantification software | https://www.bio-rad.com/fr-fr/sku/1864011-quantasoft-software-regulatory-edition?ID=1864011 |
Software, algorithm | Microwin 2000 | Berthold | Microplaque testing software | https://fr.freedownloadmanager.org/Windows-PC/MikroWin-2000.html |
Software, algorithm | LSM780 Zeiss confocal microscope | Zeiss | Microscope software | N/A |
Software, algorithm | Compass for SW | Protein Simple | Capillary Western software | N/A |
IRES activities in normoxic and hypoxic HL-1 cells after Neat1 knock-down.
HL-1 cells were transduced with Lucky Luke bicistronic lentivector containing the IRES of FGF1 mRNA. Cells were submitted to normoxia or hypoxia 1% O2 during 4 hr, 8 hr or 24 hr. Renilla and firefly luciferase activities were measured (page 1) and the IRES activities evaluated with the ratio LucF/LucR (page 2). Mann-Whitney test was performed with n=12. **P<0.01. For each hypoxia condition the mean of the LucF/LucR ratio has been calculated with 12 cell culture biological replicates, normalized to normoxia Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3, 4 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (36 technical replicates in total).
Sequences of FISH and smiFISH probes, PCR primers, gapmers, siRNAs and Fluidigm probes.
A/ FISH and smiFISH probes. B/ qPCR primers and cloning primers. C/ LNA gapmers used in Neat1 knock-down assays. D/ SiRNA SMARTpools (Dharmacon) used for IRES activity studies. E/ Fluidigm deltagene primers. The corresponding genes are indicated in the left column.
IRES activities in normoxic and hypoxic HL-1 cells after Neat1 knock-down.
HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with a pool of gapmers Neat1, or control during normoxia or hypoxia 1% O2. For the lentivector with FGF1 IRES, cells were also treated with the gapmer Neat1_2 (N1_2, page 2). Renilla and firefly luciferase activities were measured (upper panel) and the IRES activities evaluated with the ratio LucF/LucR (lower panel). Mann-Whitney test was performed with n=9. *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).
FGF1 IRES activity in normoxic and hypoxic HL-1 cells after Sfpq, Rps2, Hnrnpm knock-down.
HL-1 cells were transduced with a Lucky Luke bicistronic lentivector containing the IRES of FGF1. Cells were then treated with siSfpq (A), siRps2 (B), sihnRNPM (C), siNucleolin (siNcl, D) or siControl (siCtrl) smartpools during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured and the IRES activities evaluated with the ratio LucF/LucR. Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each siRNA the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).
IRES activities in normoxic and hypoxic HL-1 cells after p54nrb knock-down.
HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with siP54nrb or siControl (siCtrl) smartpool during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured (upper panel, or page 1 for FGF1 IRES) and the IRES activities evaluated with the ratio LucF/LucR (lower panel, or page 2 for FGF1 IRES). Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).
IRES activities in normoxic and hypoxic HL-1 cells after Pspc1 knock-down.
HL-1 cells were transduced with Lucky Luke bicistronic lentivectors containing the IRES of FGF1, FGF2, VEGFA (IRES a or b), VEGFC, VEGFD, IGF1R, MYC or EMCV. Cells were then treated with siPSPC1 or siControl (siCtrl) smartpool during normoxia or hypoxia 1% O2. Renilla and firefly luciferase activities were measured (upper panel, or page 1 for FGF1 IRES) and the IRES activities evaluated with the ratio LucF/LucR (lower panel, or page 2 for FGF1 IRES). Mann-Whitney test was performed with n=9 (n=12 for FGF1 IRES). *P<0.05, **P<0.01, ***<0.001, ****P<0.0001. For each IRES the mean has been calculated with nine cell culture biological replicates Experiments A, B, C correspond to experiments performed at different dates, while 1, 2, 3 are experiments performed in parallel at the same date, each of them being already the mean of three technical replicates (27 technical replicates in total).
Label-free quantitative analysis of HA-P54nrb-bound proteins identified by mass spectrometry in different conditions.
p54nrb-HA transduced HL-1 cells were subjected to normoxia or hypoxia, then nucleus and cytoplasm fractionation was performed and extracts were immunoprecipitated using anti-HA antibody. Enriched interacting proteins were identified by using a label-free quantitative mass spectrometry approach. The dataset list of proteins identified by MS/MS is presented in alphabetical order. An unpaired bilateral student t-test with equal variance was used. Enrichment significance thresholds correspond to an absolute log2-transformed fold-change (FC) greater than 1 and a -log10-transformed (p-value) greater than 1.3.
Change of mRNA recruitment into polysomes following Neat1 or Neat1_2 knock-down.
HL-1 cardiomyocytes were transfected with gapmer Neat1, Neat1_2, or control. Polysomes were purified on sucrose gradient as described in Star Methods. RNAs were purified from cytoplasmic extracts and from pooled polysomal fractions and analyzed on a Fluidigm deltagene PCR array from two biologicals replicates (cell culture dishs and cDNAs), each of them measured in three technical replicates (PCR reactions). mRNA levels in polysomes (polysomal RNA/ total RNA) were analyzed for each gene. Relative quantification (RQ) of mRNA level was calculated using the 2–ΔΔCT method with normalization to Gapdh mRNA and to HL-1 tranfected by gapmer control, and is shown as fold change of expression. RQ1 and RQ2 correspond to two independent experiments. To measure the fold change of repression, the mean is expressed as –1/RQ for the values <1 (yellow column).